3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Sunburn
1
Stress, Psychological
1
Stress Disorders, Post-Traumatic
1
Smoking Cessation
1
Sarcoma
1
Prostatic Hyperplasia
1
Motor Activity
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Digestive System Abnormalities
1
Depression
1
Central Nervous System Neoplasms
1
Anxiety Disorders
1
Alzheimer Disease
1
Acquired Immunodeficiency Syndrome
1
Interventions
Tobacco Use Cessation Devices
2
Surveys and Questionnaires
2
Nivolumab
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Electrocoagulation
2
Biopsy
2
fludarabine phosphate
1
fludarabine
1
Watchful Waiting
1
Trichloroacetic Acid
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Tacrolimus
1
Self Care
1
Ritonavir
1
Registries
1
Rapid Diagnostic Tests
1
Proctoscopy
1
Papillomavirus Vaccines
1
Occult Blood
1
Observation
1
Nevirapine
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Melphalan
1
Mass Screening
1
Mammography
1
Lopinavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Acquired Immunodeficiency Syndrome
×
Amyloid
×
Clear all
NCT06883097
2025-12-17
QMH
Wake Forest University Health Sciences
Phase NA
Recruiting
314 enrolled